Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT).
PaperCitations, authors & open-access status
Clinical and biomarker results of neoadjuvant phase II study of pembrolizumab and carboplatin plus docetaxel in triple-negative breast cancer (TNBC) (NeoPACT). is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 51 citations, 2022 year and closed oa status.
51
Citations
2022
Year
closed
OA Status